Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fu's Subcutaneous Needling for Migraine Without Aura
NCT07068815Phase 1Not yet recruiting
- Sponsor
- Guangzhou University of Chinese Medicine
- Start
- Sep 2025
- Primary completion
- Mar 2027
01
Overview
Phase 1, randomised trial (2 arms), sponsored by Guangzhou University of Chinese Medicine. Primary endpoint: Visual Analog Scale at Day 112. Planned start Sep 2025; status: not yet recruiting.
Beyond the preview
Go deeper on NCT07068815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07068815.